Press coverage about Surgery Partners (NASDAQ:SGRY) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Surgery Partners earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.7888585459438 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Several equities research analysts have recently issued reports on the company. KeyCorp reaffirmed a “hold” rating on shares of Surgery Partners in a research note on Tuesday, October 31st. ValuEngine lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Friday, February 2nd. Zacks Investment Research lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Tuesday, February 6th. Benchmark set a $19.00 price objective on Surgery Partners and gave the company a “buy” rating in a research note on Tuesday, January 30th. Finally, Jefferies Group lowered their price objective on Surgery Partners from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 1st. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. Surgery Partners has an average rating of “Hold” and an average target price of $17.86.
Shares of Surgery Partners (NASDAQ:SGRY) opened at $16.20 on Friday. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56. Surgery Partners has a fifty-two week low of $7.10 and a fifty-two week high of $24.05. The firm has a market capitalization of $760.80, a P/E ratio of -35.22 and a beta of 2.47.
Surgery Partners announced that its Board of Directors has authorized a stock repurchase program on Friday, December 15th that allows the company to repurchase $50.00 million in outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: This article was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2018/02/16/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-surgery-partners-sgry-stock-price.html.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.